Page last updated: 2024-08-22

galactosamine and acy-1215

galactosamine has been researched along with acy-1215 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gong, ZJ; Jiao, FZ; Wang, LW; Zhang, H; Zhang, HY; Zhang, WB	1

Other Studies

1 other study(ies) available for galactosamine and acy-1215

Article	Year
Histone deacetylase 6 inhibitor ACY-1215 protects against experimental acute liver failure by regulating the TLR4-MAPK/NF-κB pathway. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 97 Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cytokines; Disease Models, Animal; Galactosamine; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Hydroxamic Acids; Inflammation; Lipopolysaccharides; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4	2018

Article

Year

Histone deacetylase 6 inhibitor ACY-1215 protects against experimental acute liver failure by regulating the TLR4-MAPK/NF-κB pathway.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 97

Topics: Animals; Anti-Inflammatory Agents; Blotting, Western; Cytokines; Disease Models, Animal; Galactosamine; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Hydroxamic Acids; Inflammation; Lipopolysaccharides; Liver Failure, Acute; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4

2018